280 related articles for article (PubMed ID: 35008399)
21. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.
Kageyama T; Nakamura M; Matsuo A; Yamasaki Y; Takakura Y; Hashida M; Kanai Y; Naito M; Tsuruo T; Minato N; Shimohama S
Brain Res; 2000 Oct; 879(1-2):115-21. PubMed ID: 11011012
[TBL] [Abstract][Full Text] [Related]
22. Essential Roles of L-Type Amino Acid Transporter 1 in Syncytiotrophoblast Development by Presenting Fusogenic 4F2hc.
Ohgaki R; Ohmori T; Hara S; Nakagomi S; Kanai-Azuma M; Kaneda-Nakashima K; Okuda S; Nagamori S; Kanai Y
Mol Cell Biol; 2017 Jun; 37(11):. PubMed ID: 28320871
[TBL] [Abstract][Full Text] [Related]
23. Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics.
Kanai Y
Pharmacol Ther; 2022 Feb; 230():107964. PubMed ID: 34390745
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the system L amino acid transporter in T24 human bladder carcinoma cells.
Kim DK; Kanai Y; Choi HW; Tangtrongsup S; Chairoungdua A; Babu E; Tachampa K; Anzai N; Iribe Y; Endou H
Biochim Biophys Acta; 2002 Sep; 1565(1):112-21. PubMed ID: 12225859
[TBL] [Abstract][Full Text] [Related]
25. Expression of LAT1 predicts risk of progression of transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Ogata S; Matsuo H; Kanai Y; Endou H; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Kawai T
Virchows Arch; 2007 Sep; 451(3):681-90. PubMed ID: 17622555
[TBL] [Abstract][Full Text] [Related]
26. Small molecule inhibitors provide insights into the relevance of LAT1 and LAT2 in materno-foetal amino acid transport.
Zaugg J; Huang X; Ziegler F; Rubin M; Graff J; Müller J; Moser-Hässig R; Powell T; Gertsch J; Altmann KH; Albrecht C
J Cell Mol Med; 2020 Nov; 24(21):12681-12693. PubMed ID: 33001560
[TBL] [Abstract][Full Text] [Related]
27. Putative roles of SLC7A5 (LAT1) transporter in pain.
Alles SRA; Gomez K; Moutal A; Khanna R
Neurobiol Pain; 2020; 8():100050. PubMed ID: 32715162
[TBL] [Abstract][Full Text] [Related]
28. Human L-type amino acid transporter 1 (LAT1): characterization of function and expression in tumor cell lines.
Yanagida O; Kanai Y; Chairoungdua A; Kim DK; Segawa H; Nii T; Cha SH; Matsuo H; Fukushima J; Fukasawa Y; Tani Y; Taketani Y; Uchino H; Kim JY; Inatomi J; Okayasu I; Miyamoto K; Takeda E; Goya T; Endou H
Biochim Biophys Acta; 2001 Oct; 1514(2):291-302. PubMed ID: 11557028
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of LAT1 expression suppresses cholangiocarcinoma cell invasion and migration.
Janpipatkul K; Suksen K; Borwornpinyo S; Jearawiriyapaisarn N; Hongeng S; Piyachaturawat P; Chairoungdua A
Cell Signal; 2014 Aug; 26(8):1668-79. PubMed ID: 24726839
[TBL] [Abstract][Full Text] [Related]
30. Function and structure of heterodimeric amino acid transporters.
Wagner CA; Lang F; Bröer S
Am J Physiol Cell Physiol; 2001 Oct; 281(4):C1077-93. PubMed ID: 11546643
[TBL] [Abstract][Full Text] [Related]
31. The heterodimeric amino acid transporter 4F2hc/LAT1 is associated in Xenopus oocytes with a non-selective cation channel that is regulated by the serine/threonine kinase sgk-1.
Wagner CA; Bröer A; Albers A; Gamper N; Lang F; Bröer S
J Physiol; 2000 Jul; 526 Pt 1(Pt 1):35-46. PubMed ID: 10878097
[TBL] [Abstract][Full Text] [Related]
32. Genetic Disruption of the Multifunctional CD98/LAT1 Complex Demonstrates the Key Role of Essential Amino Acid Transport in the Control of mTORC1 and Tumor Growth.
Cormerais Y; Giuliano S; LeFloch R; Front B; Durivault J; Tambutté E; Massard PA; de la Ballina LR; Endou H; Wempe MF; Palacin M; Parks SK; Pouyssegur J
Cancer Res; 2016 Aug; 76(15):4481-92. PubMed ID: 27302165
[TBL] [Abstract][Full Text] [Related]
33. L-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors.
Nawashiro H; Otani N; Shinomiya N; Fukui S; Ooigawa H; Shima K; Matsuo H; Kanai Y; Endou H
Int J Cancer; 2006 Aug; 119(3):484-92. PubMed ID: 16496379
[TBL] [Abstract][Full Text] [Related]
34. Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
Ogawa H; Kaira K; Motegi Y; Yokobori T; Takada T; Katoh R; Osone K; Takahashi R; Katayama C; Oyama T; Kanai Y; Yao T; Asao T; Kuwano H; Shirabe K
Anticancer Res; 2019 May; 39(5):2535-2543. PubMed ID: 31092450
[TBL] [Abstract][Full Text] [Related]
35. Relation of LAT1/4F2hc expression with pathological grade, proliferation and angiogenesis in human gliomas.
Haining Z; Kawai N; Miyake K; Okada M; Okubo S; Zhang X; Fei Z; Tamiya T
BMC Clin Pathol; 2012 Feb; 12():4. PubMed ID: 22373026
[TBL] [Abstract][Full Text] [Related]
36. Targeting Amino Acid Metabolic Reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer.
Shindo H; Harada-Shoji N; Ebata A; Sato M; Soga T; Miyashita M; Tada H; Kawai M; Kosaka S; Onuki K; Usami S; Furumoto S; Hayashi S; Abe T; Suzuki T; Ishida T; Sasano H
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503187
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of system y(+)-like amino acid transport by the heavy chain of human 4F2 surface antigen in Xenopus laevis oocytes.
Bertran J; Magagnin S; Werner A; Markovich D; Biber J; Testar X; Zorzano A; Kühn LC; Palacin M; Murer H
Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5606-10. PubMed ID: 1376926
[TBL] [Abstract][Full Text] [Related]
38. JPH203, a selective L-type amino acid transporter 1 inhibitor, induces mitochondria-dependent apoptosis in Saos2 human osteosarcoma cells.
Choi DW; Kim DK; Kanai Y; Wempe MF; Endou H; Kim JK
Korean J Physiol Pharmacol; 2017 Nov; 21(6):599-607. PubMed ID: 29200902
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of non-functional LAT1/4F2hc in renal proximal tubular epithelial cells from the spontaneous hypertensive rat.
Pinho MJ; Serrão MP; Jose PA; Soares-da-Silva P
Cell Physiol Biochem; 2007; 20(5):535-48. PubMed ID: 17762180
[TBL] [Abstract][Full Text] [Related]
40. The Nutraceutical Alliin From Garlic Is a Novel Substrate of the Essential Amino Acid Transporter LAT1 (SLC7A5).
Scanga R; Scalise M; Rovella F; Regina TMR; Galluccio M; Indiveri C
Front Pharmacol; 2022; 13():877576. PubMed ID: 35401172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
